BRAIN REGULATION OF BLOOD GLUCOSE LEVELS: ITS SIGNIFICANCE IN THE PATHOGENESIS OF TYPE 2 DIABETES

Main Article Content

Yuldasheva Mohigul Turdaliyevna
Arslonbek Ikromiy Ilhomjon ugli

Abstract

Although the number of studies is rapidly increasing, the role of the brain in regulating normal glucose homeostasis and the pathogenesis of type 2 diabetes remains incompletely understood. In this review, we propose a conceptual framework to better understand the brain’s critical role in these processes. This framework is based on evidence showing that the brain, like the pancreas, is capable of sensing changes in circulating glucose levels and responding accordingly. We also examine data suggesting that neuronal glucose sensing plays a fundamental role in determining the defended (physiologically maintained) level of blood glucose and that defects in this regulatory system contribute to the pathogenesis of type 2 diabetes. Furthermore, we discuss the close link between obesity and type 2 diabetes, which may arise from shared dysfunction in highly integrated neurocircuits that regulate both energy and glucose homeostasis. Thus, while obesity is characterized by an elevated defended level of the body’s fuel stores (e.g., adipose tissue mass), type 2 diabetes is characterized by an elevated defended level of circulating fuel (e.g., glucose). In both conditions, the underlying pathogenesis is associated with impaired sensing of, or response to, relevant humoral negative feedback signals. This perspective is increasingly supported by preclinical evidence: in type 2 diabetes, restoration of the defended blood glucose level to normal can be achieved through interventions that restore the brain’s ability to accurately sense circulating glucose.

Downloads

Download data is not yet available.

Article Details

Section

Articles

How to Cite

BRAIN REGULATION OF BLOOD GLUCOSE LEVELS: ITS SIGNIFICANCE IN THE PATHOGENESIS OF TYPE 2 DIABETES. (2025). Journal of Multidisciplinary Sciences and Innovations, 4(11), 528-538. https://doi.org/10.55640/

References

1. D Alessio DA, Kieffer TJ, Taborsky GJ Jr, Havel PJ (2001)

Activation of the parasympathetic nervous system is necessary for

normal meal-induced insulin secretion in rhesus macaques. J Clin

Endocrinol Metab 86(3):1253–1259. https://doi.org/10.1210/jcem.

86.3.7367

2. Carey M, Lontchi-Yimagou E, Mitchell W et al (2020) Central

KATP channels modulate glucose effectiveness in humans and

rodents. Diabetes 69(6):1140–1148. https://doi.org/10.2337/db19-

1256

3. Bernard C (1849) Chiens rendus diabetiques. C R Soc Bio 1:60

4. Oh Y, Lai JS, Mills HJ et al (2019) A glucose-sensing neuron pair

regulates insulin and glucagon in Drosophila. Nature 574(7779):

559–564. https://doi.org/10.1038/s41586-019-1675-4

5. Schwartz MW, Seeley RJ, Tschöp MH et al (2013) Cooperation

between brain and islet in glucose homeostasis and diabetes. Nature

503(7474):59–66. https://doi.org/10.1038/nature12709

6. Pardridge WM, Triguero D, Farrell CR (1990) Downregulation of

blood-brain barrier glucose transporter in experimental diabetes.

Diabetes 39(9):1040–1044. https://doi.org/10.2337/diab.39.9.1040

12 Diabetologia (2021) 64:5–14

7. Cornford EM, Hyman S, Cornford ME, Clare-Salzler M (1995)

Down-regulation of blood-brain glucose transport in the hyperglycemic nonobese diabetic mouse. Neurochem Res 20(7):869–873.

https://doi.org/10.1007/bf00969700

8. Hwang JJ, Jiang L, Hamza M et al (2017) Blunted rise in brain

glucose levels during hyperglycemia in adults with obesity and

T2DM. JCI Insight 2(20):e95913. https://doi.org/10.1172/jci.

insight.95913

9. Eskian M, Alavi A, Khorasanizadeh M et al (2019) Effect of blood

glucose level on standardized uptake value (SUV) in 18F-FDG

PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements. Eur J Nucl Med Mol Imaging 46(1):

224–237. https://doi.org/10.1007/s00259-018-4194-x

10. Sprinz C, Altmayer S, Zanon M et al (2018) Effects of blood

glucose level on 18F-FDG uptake for PET/CT in normal organs:

a systematic review. PLoS One 13(2):e0193140. https://doi.org/10.

1371/journal.pone.0193140

11. Li W, Risacher SL, Huang E, Saykin AJ (2016) Type 2 diabetes

mellitus is associated with brain atrophy and hypometabolism in the

ADNI cohort. Neurology 87(6):595–600. https://doi.org/10.1212/

wnl.0000000000002950

12. Thorens B (2015) GLUT2, glucose sensing and glucose homeostasis. Diabetologia 58(2):221–232. https://doi.org/10.1007/s00125-

014-3451-1

13. Ma Y, Ratnasabapathy R, De Backer I et al (2020) Glucose in the

hypothalamic paraventricular nucleus regulates GLP-1 release. JCI

Insight 5(8):e132760. https://doi.org/10.1172/jci.insight.132760

14. Nishio T, Toyoda Y, Hiramatsu M, Chiba T, Miwa I (2006) Decline

in glucokinase activity in the arcuate nucleus of streptozotocininduced diabetic rats. Biol Pharm Bull 29(2):216–219. https://doi.

org/10.1248/bpb.29.216

15. Ma Y, Ratnasabapathy R, Izzi-Engbeaya C et al (2018)

Hypothalamic arcuate nucleus glucokinase regulates insulin secretion and glucose homeostasis. Diabetes Obes Metab 20(9):2246–

2254. https://doi.org/10.1111/dom.13359

16. Kang L, Dunn-Meynell AA, Routh VH et al (2006) Glucokinase is

a critical regulator of ventromedial hypothalamic neuronal

glucosensing. Diabetes 55(2):412–420. https://doi.org/10.2337/

diabetes.55.02.06.db05-1229

17. Cryer PE (1993) Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Phys 264(2 Pt 1):E149–

E155. https://doi.org/10.1152/ajpendo.1993.264.2.E149

18. Asplin CM, Raghu PK, Koerker DJ, Palmer JP (1985) Glucose

counterregulation during recovery from neuroglucopenia: which

mechanism is important? Metabolism 34(1):15–18. https://doi.

org/10.1016/0026-0495(85)90053-8

19. Meek TH, Nelson JT, Matsen ME et al (2016) Functional identification of a neurocircuit regulating blood glucose. Proc Natl Acad

Sci U S A 113(14):E2073–E2082. https://doi.org/10.1073/pnas.

1521160113

20. Faber CL, Matsen ME, Velasco KR et al (2018) Distinct neuronal

projections from the hypothalamic ventromedial nucleus mediate

glycemic and behavioral effects. Diabetes 67(12):2518–2529.

https://doi.org/10.2337/db18-0380

21. Flak JN, Goforth PB, Dell Orco J et al (2020) Ventromedial hypothalamic nucleus neuronal subset regulates blood glucose independently of insulin. J Clin Invest 130(6):2943–2952. https://doi.org/

10.1172/jci134135

22. Chakera AJ, Hurst PS, Spyer G et al (2018) Molecular reductions in

glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes. Mol Metab 17:17–27.

https://doi.org/10.1016/j.molmet.2018.08.001

23. Spyer G, Hattersley AT, MacDonald IA, Amiel S, MacLeod KM

(2000) Hypoglycaemic counter-regulation at normal blood glucose

concentrations in patients with well controlled type-2 diabetes.

Lancet 356(9246):1970–1974. https://doi.org/10.1016/s0140-

6736(00)03322-5

24. Chowdhury GMI, Wang P, Ciardi A et al (2017) Impaired glutamatergic neurotransmission in the ventromedial hypothalamus may

contribute to defective counterregulation in recurrently hypoglycemic rats. Diabetes 66(7):1979–1989. https://doi.org/10.2337/db16-

1589

25. Tong Q, Ye C, McCrimmon RJ et al (2007) Synaptic glutamate

release by ventromedial hypothalamic neurons is part of the

neurocircuitry that prevents hypoglycemia. Cell Metab 5(5):383–

393. https://doi.org/10.1016/j.cmet.2007.04.001

26. Roncero I, Alvarez E, Chowen JA et al (2004) Expression of

glucose transporter isoform GLUT-2 and glucokinase genes in

human brain. J Neurochem 88(5):1203–1210. https://doi.org/10.

1046/j.1471-4159.2003.02269.x

27. Woods SC, Porte D Jr (1974) Neural control of the endocrine

pancreas. Physiol Rev 54(3):596–619. https://doi.org/10.1152/

physrev.1974.54.3.596

28. Osundiji MA, Evans ML (2013) Brain control of insulin and glucagon secretion. Endocrinol Metab Clin N Am 42(1):1–14. https://

doi.org/10.1016/j.ecl.2012.11.006

29. Tang SC, Baeyens L, Shen CN et al (2018) Human pancreatic

neuro-insular network in health and fatty infiltration. Diabetologia

61(1):168–181. https://doi.org/10.1007/s00125-017-4409-x

30. Havel PJ, Veith RC, Dunning BE, Taborsky GJ Jr (1988)

Pancreatic noradrenergic nerves are activated by neuroglucopenia

but not by hypotension or hypoxia in the dog. Evidence for stressspecific and regionally selective activation of the sympathetic

nervous system. J Clin Invest 82(5):1538–1545. https://doi.org/

10.1172/JCI113763

Similar Articles

You may also start an advanced similarity search for this article.